Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke

Sponsor
Medical University of South Carolina (Other)
Overall Status
Recruiting
CT.gov ID
NCT04569123
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
76
1
2
60
1.3

Study Details

Study Description

Brief Summary

The objective of this study is to determine if combining vibration with hand task practice is superior to hand task practice alone.

Condition or Disease Intervention/Treatment Phase
  • Device: real stimulation
  • Device: No stimulation
N/A

Detailed Description

Stroke is a leading cause of disability in the U.S., with more than 4 million stroke survivors in the U.S. who suffer from post-stroke hand disability. Post-stroke hand disability impairs stroke survivors' abilities and independence with self-care, hygiene, employment, and leisure, frequently resulting in diminished quality of life. Rehabilitation can often be limited, but research suggests that the effects of therapy is improved by the addition of sensory stimulation.

To fully leverage the potential therapeutic benefits of sensory stimulation, we have developed a new stimulation that is imperceptible random-frequency vibration applied to wrist skin. The objective of this study is to determine if this treatment is superior to task-practice alone in improving hand functional recovery, sensorimotor grip control, and neural communication.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
76 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke
Actual Study Start Date :
Nov 2, 2020
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Nov 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Vibration

The device will deliver imperceptible vibration for the treatment group.

Device: real stimulation
Participants will undergo standardized hand task practice therapy (3 sessions/week for 6 weeks) with the watch worn on the paretic wrist. Participants will be randomized into two groups: The device will deliver vibration for the treatment group.

Sham Comparator: No Vibration

The device will deliver no vibration for the control group.

Device: No stimulation
Participants will undergo standardized hand task practice therapy (3 sessions/week for 6 weeks) with the watch worn on the paretic wrist. Participants will be randomized into two groups: The device will deliver no vibration for the control group during therapy.

Outcome Measures

Primary Outcome Measures

  1. Change in Score of Wolf Motor Function Test (WMFT) [Baseline and 6 weeks]

    Timed test of upper extremity function with a variety of tasks.

Secondary Outcome Measures

  1. Change in Score of Box and Blocks Test [Baseline and 6 weeks]

    Timed test of upper extremity function by moving blocks.

  2. Change in Score of Action Research Arm Test [Baseline and 6 weeks]

    Timed test of upper extremity function through a variety of tasks.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years old or older

  • At least 6 months since stroke

  • Wolf Motor Function Test (WMFT) total average time >10 seconds

  • WFMT hand task average time <120 s

Exclusion Criteria:
  • Currently undergoing other upper limb therapy

  • Change in spasticity medication or upper limb botulinum toxin injection within 3 months prior to or during enrollment

  • Severe spasticity (Modified Ashworth Scale=4-5)

  • Comorbidity such as complete upper extremity deafferentation, orthopaedic conditions limiting motion, premorbid neurologic conditions, peripheral neuropathy, or compromised skin integrity of the wrist due to burn or long-term use of blood thinners

  • Language barrier or cognitive impairment that precludes following instructions and/or providing consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of South Carolina Charleston South Carolina United States 29403

Sponsors and Collaborators

  • Medical University of South Carolina
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Na Jin Seo, Associate Professor, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT04569123
Other Study ID Numbers:
  • Pro90790
  • 1R01HD094731-01A1
First Posted:
Sep 29, 2020
Last Update Posted:
Nov 30, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Na Jin Seo, Associate Professor, Medical University of South Carolina
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2021